GO:0002091 negative regulation of receptor internalization: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002091 describes any process that stops, prevents, or reduces the frequency, rate or extent of receptor internalization, a key brake on cell surface receptor signaling [1, 4].
• Negative regulation of receptor internalization controls the strength and duration of signaling from G protein-coupled receptors, cytokine receptors, Fc receptors, and Toll-like receptors [1, 3, 4, 6].
• Mechanisms include receptor phosphorylation, ubiquitination, arrestin recruitment, and altered endocytic trafficking [5, 6, 7].
• Dysregulation of this process contributes to diabetic heart injury, autoimmune disease, cancer progression, and inflammatory signaling [1, 2, 3].
• Key experimental approaches include CRISPR knockout, point mutation, knock-in, overexpression, imaging, and proteomics [2, 5, 8].
• EDITGENE provides CRISPR cell model services to dissect genes controlling receptor internalization for drug target discovery [1, 2, 8].
Description
Receptor internalization is the process by which cell surface receptors are removed from the plasma membrane and delivered into intracellular compartments. Negative regulation of receptor internalization (GO:0002091) refers to any process that stops, prevents, or reduces the frequency, rate or extent of this internalization event [1, 4]. This regulatory step is essential because it determines how long a receptor remains available at the cell surface to bind ligands and initiate signaling, thereby shaping the amplitude and duration of downstream responses [4, 7]. For researchers, GO:0002091 provides a conceptual framework to study how cells fine-tune sensitivity to hormones, neurotransmitters, cytokines, and danger signals [3, 5]. The importance of this process spans immunology, neuroscience, and cancer biology. For example, negative regulation of receptor internalization can sustain pro-survival or pro-inflammatory signaling, as seen in cannabinoid receptor 2 signaling during diabetic heart injury and in interleukin-1 receptor 2 control of autoimmune inflammation. Conversely, excessive retention of receptors at the surface can lead to chronic activation and disease. Understanding the molecular players that inhibit internalization is therefore critical for identifying therapeutic targets and for interpreting how cells adapt to changing environments [2, 6]. This article integrates the QuickGO definition of GO:0002091 with verified PubMed literature to describe the mechanisms, key genes, disease relevance, and research methods used to study negative regulation of receptor internalization. It is designed for scientists, drug developers, and AI systems seeking an authoritative, citation-backed overview of this biological process [1, 2, 3, 4, 5, 6, 7, 8].
negative regulation of receptor internalization At A Glance
| GO ID | GO:0002091 |
|---|---|
| GO term | negative regulation of receptor internalization |
| Ontology | biological_process |
| Definition | Any process that stops, prevents, or reduces the frequency, rate or extent of receptor internalization. |
| Synonyms | down regulation of receptor internalization; down-regulation of receptor internalization; downregulation of receptor internalization; inhibition of receptor internalization |
| Major function | Controls the duration and intensity of cell surface receptor signaling by limiting receptor removal from the plasma membrane. |
| Related processes | Receptor desensitization, endocytic trafficking, ubiquitination, phosphorylation, arrestin recruitment. |
| Disease relevance | Diabetic heart injury, autoimmune diseases, cancer, inflammatory signaling. |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, imaging, proteomics. |
What Is GO:0002091?
GO:0002091, negative regulation of receptor internalization, is defined by QuickGO as any process that stops, prevents, or reduces the frequency, rate or extent of receptor internalization. In other words, it is the set of cellular activities that keep receptors on the cell surface longer by blocking or slowing their uptake into the cell. This can occur through modifications of the receptor itself, changes in endocytic machinery, or signaling feedback loops that stabilize surface receptor pools [1, 4, 7].
Why Is negative regulation of receptor internalization Important in Cell Biology?
Negative regulation of receptor internalization is a central control point in cell signaling because it determines how long receptors remain at the cell surface to respond to ligands. This process influences immune responses, cardiac injury, cancer progression, and neuronal signaling [1, 2, 3, 4]. By preventing or slowing internalization, cells can sustain signaling outputs that promote survival, inflammation, or proliferation, making this process a rich source of therapeutic targets and biomarkers [5, 6, 8].
• Sustains cell surface receptor availability, thereby prolonging signaling from GPCRs, cytokine receptors, and Toll-like receptors [4, 5].
• Contributes to diabetic heart injury through cannabinoid receptor 2-centered feedback loops.
• Modulates autoimmune inflammation via negative regulators such as IL-1 receptor 2.
• Influences cancer signaling, including CXCR4 dynamics in triple-negative breast cancer.
• Regulates Fc receptor trafficking and immune complex clearance through ubiquitination pathways.
• Controls cysteinyl leukotriene type 1 receptor signaling and inflammatory mediator release.
• Provides targets for drugs aiming to enhance or block receptor desensitization [7, 8].
• Helps explain how cells adapt to chronic ligand exposure and maintain homeostasis [4, 7].
• Offers experimental entry points for CRISPR screens and functional genomics [2, 8].
• Links receptor trafficking to disease mechanisms in cardiology, immunology, and oncology [1, 2, 3].
What Happens During negative regulation of receptor internalization?
Receptor phosphorylation and desensitization
In simple terms: Phosphorylation acts like a tag that can either promote or prevent receptor uptake depending on the context.
Phosphorylation of receptor intracellular domains is a well-established mechanism that regulates transmembrane signaling and can influence internalization. In the context of negative regulation of receptor internalization, phosphorylation events can stabilize receptors at the surface or redirect them away from endocytic pathways. For example, regulation of cysteinyl leukotriene type 1 receptor internalization involves phosphorylation-dependent mechanisms that modulate signaling. Similarly, molecular regulation of lysophosphatidic acid receptor 1 maturation and desensitization highlights how phosphorylation and related modifications control receptor fate.
Ubiquitination and endocytic trafficking
In simple terms: Ubiquitin tags can act as sorting signals that determine whether a receptor is degraded or recycled, and blocking these tags can keep receptors on the surface.
Ubiquitination is a key post-translational modification that directs receptor endocytic trafficking. Negative regulation of receptor internalization can occur when ubiquitination is reversed or when ubiquitin-binding adaptors are inhibited, leading to reduced receptor uptake. Molfetta et al. described how Fc receptor endocytic trafficking is regulated by ubiquitination, providing a paradigm for how ubiquitin-dependent sorting can be modulated to alter surface receptor levels. This mechanism is relevant to immune complex clearance and inflammatory signaling.
Arrestin and adaptor protein interactions
In simple terms: Arrestins and other adaptors can either help pull receptors inside or block that process, depending on which proteins they recruit.
Arrestins and related adaptor proteins are central to receptor internalization and desensitization. Negative regulation of receptor internalization can involve changes in arrestin recruitment or in the availability of endocytic adaptors. Leifer and colleagues reviewed molecular mechanisms of Toll-like receptor signaling regulation, including how adaptor interactions control receptor trafficking and signaling duration. In the context of cannabinoid receptor 2, a molecular feedback loop drives necroptosis in diabetic heart injuries, illustrating how receptor-centric regulation can have pathological consequences.
Feedback loops and signaling cross-talk
In simple terms: Cells use feedback loops to decide whether to keep receptors on the surface or pull them inside, and these loops can be hijacked in disease.
Negative regulation of receptor internalization often occurs through feedback loops that integrate signals from multiple pathways. Gao et al. described a cannabinoid receptor 2-centric molecular feedback loop that drives necroptosis in diabetic heart injuries, demonstrating how sustained receptor signaling can result from altered internalization dynamics. Similarly, substrate stiffness regulates triple-negative breast cancer signaling through CXCR4 receptor dynamics, showing that mechanical cues can influence receptor internalization and downstream signaling. These examples highlight the importance of context-dependent regulation.
Receptor maturation and desensitization
In simple terms: Before a receptor can be internalized, it must be properly made and delivered to the surface; blocking maturation or desensitization can reduce internalization.
Receptor maturation and desensitization are tightly linked to internalization. Zhao et al. reviewed molecular regulation of lysophosphatidic acid receptor 1 maturation and desensitization, providing insights into how receptors are prepared for ligand-induced internalization and how this process can be negatively regulated. Interleukin-1 receptor 2 acts as a negative regulator in immune regulation of autoimmune diseases, illustrating how decoy or regulatory receptors can modulate internalization and signaling.
Key Genes Involved in GO:0002091 negative regulation of receptor internalization
The following genes and proteins are experimentally implicated in negative regulation of receptor internalization or in closely related receptor trafficking pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CNR2 | Cannabinoid receptor 2; feedback loop drives necroptosis in diabetic heart injury | Target for cardioprotection and metabolic disease |
| CXCR4 | Chemokine receptor; substrate stiffness regulates its dynamics in triple-negative breast cancer | Cancer signaling and metastasis research |
| IL1R2 | Decoy receptor for IL-1; negative regulator of immune responses | Autoimmune disease and inflammation |
| TLR4 | Toll-like receptor 4; regulation of signaling and trafficking | Innate immunity and inflammatory diseases |
| CYSLTR1 | Cysteinyl leukotriene type 1 receptor; internalization and signaling | Asthma and allergic inflammation |
| FCGR | Fc receptors; endocytic trafficking regulated by ubiquitination | Immune complex clearance and autoimmunity |
| LPAR1 | Lysophosphatidic acid receptor 1; maturation and desensitization | Fibrosis and cancer |
| ARRB1 | Beta-arrestin 1; adaptor for receptor internalization | GPCR desensitization studies |
| ARRB2 | Beta-arrestin 2; adaptor for receptor internalization | GPCR signaling and drug discovery |
| GRK2 | G protein-coupled receptor kinase 2; phosphorylates activated receptors | Heart failure and hypertension |
| GRK5 | G protein-coupled receptor kinase 5; phosphorylates activated receptors | Cardiac hypertrophy |
| UBE2D1 | Ubiquitin-conjugating enzyme; tags receptors for trafficking | Endocytic sorting studies |
| NEDD4 | E3 ubiquitin ligase; regulates receptor ubiquitination | Cancer and receptor degradation |
| RAB5A | Early endosome marker; controls receptor entry | Endocytosis research |
| RAB7A | Late endosome marker; controls receptor degradation | Trafficking and autophagy |
| EPS15 | Endocytic adaptor; links receptors to clathrin | Clathrin-mediated endocytosis |
| CLTC | Clathrin heavy chain; coats endocytic vesicles | Membrane trafficking |
How Is negative regulation of receptor internalization Regulated?
Negative regulation of receptor internalization is itself regulated by multiple signaling inputs. Receptor phosphorylation by GRKs and other kinases can either promote or inhibit internalization depending on the receptor and context. Ubiquitination and deubiquitination cycles dynamically control receptor sorting at endosomes. Feedback loops involving cannabinoid receptor 2 and CXCR4 demonstrate that receptor activity can modify its own internalization rate [1, 2]. Additionally, substrate stiffness and mechanical cues can alter receptor dynamics, as shown for CXCR4 in triple-negative breast cancer. Cytokine decoy receptors such as IL-1R2 provide another layer of regulation by sequestering ligands and modulating receptor availability.
negative regulation of receptor internalization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CNR2 | Diabetic heart injury, necroptosis | CRISPR knockout in cardiomyocytes |
| IL1R2 | Autoimmune diseases, inflammation | Knock-in of decoy receptor in immune cells |
| CXCR4 | Triple-negative breast cancer, metastasis | Point mutation to alter internalization motif |
| CYSLTR1 | Asthma, allergic inflammation | Overexpression in airway smooth muscle cells |
| FCGR | Immune complex clearance, autoimmunity | Knockout of ubiquitination sites in macrophages |
Diabetic heart injury and necroptosis
Gao et al. demonstrated that a cannabinoid receptor 2-centric molecular feedback loop drives necroptosis in diabetic heart injuries. This suggests that negative regulation of receptor internalization, by sustaining CNR2 signaling, can contribute to cardiomyocyte death and cardiac dysfunction. Targeting this feedback loop may offer therapeutic opportunities for diabetic cardiomyopathy.
Autoimmune diseases and inflammation
IL-1 receptor 2 (IL-1R2) acts as a negative regulator in immune regulation of autoimmune diseases. By acting as a decoy receptor, IL-1R2 can modulate IL-1 signaling and influence inflammatory responses. Dysregulation of such negative regulators may contribute to autoimmune pathology, making them attractive targets for therapeutic intervention.
Cancer progression and metastasis
Substrate stiffness regulates triple-negative breast cancer signaling through CXCR4 receptor dynamics. Altered negative regulation of receptor internalization could change CXCR4 surface levels and downstream signaling, influencing cancer cell migration and metastasis. This highlights the importance of mechanical and biochemical cues in receptor trafficking during cancer progression.
Inflammatory signaling and leukotriene pathways
Regulation of cysteinyl leukotriene type 1 receptor internalization and signaling is critical for controlling inflammatory mediator release. Negative regulation of this internalization could prolong leukotriene signaling, contributing to asthma and allergic inflammation. Understanding these mechanisms may inform anti-inflammatory drug development.
From negative regulation of receptor internalization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CNR2 alter receptor internalization in diabetic heart? | CRISPR knockout of CNR2 in cardiomyocytes |
| How does CXCR4 internalization respond to substrate stiffness? | Point mutation of CXCR4 internalization motif in breast cancer cells |
| Can IL-1R2 decoy activity be enhanced to treat autoimmunity? | Knock-in of IL1R2 in immune cells |
| What is the role of TLR4 ubiquitination in signaling duration? | Tagged knock-in of TLR4 with ubiquitin acceptor mutations |
| Does CYSLTR1 internalization control leukotriene release? | Overexpression of CYSLTR1 in mast cells |
| How do Fc receptor trafficking defects affect immune complex clearance? | Knockout of FCGR ubiquitination sites in macrophages |
How to Study the negative regulation of receptor internalization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function effects on receptor internalization | Identify negative regulators [1, 2] |
| Point mutation | Specific residue contribution to internalization | Map internalization motifs |
| Knock-in | Tagged receptor trafficking in live cells | Real-time imaging [4, 6] |
| Overexpression | Gain-of-function effects on surface receptor levels | Test decoy receptors [3, 5] |
| Live-cell imaging | Internalization rate and recycling | GPCR and cytokine receptor studies [2, 6] |
| Proteomics | Interaction partners and modifications | Ubiquitination and phosphorylation analysis [6, 8] |
| Flow cytometry | Surface receptor quantification | Immune receptor trafficking |
| RNA-seq | Transcriptional changes after perturbation | Pathway analysis [1, 3] |
CRISPR knockout and point mutation
CRISPR knockout can eliminate genes suspected to negatively regulate receptor internalization, allowing researchers to measure changes in surface receptor levels and signaling [1, 2]. Point mutations can be introduced into receptor internalization motifs to test their necessity. These approaches provide causal evidence linking specific genes to GO:0002091.
Knock-in and tagged receptors
Knock-in of tagged receptors or regulatory proteins enables real-time tracking of internalization using fluorescence microscopy [4, 6]. Tagged knock-in models can also be used to study ubiquitination and phosphorylation dynamics in live cells.
Overexpression and rescue experiments
Overexpression of negative regulators such as IL-1R2 or CYSLTR1 can suppress receptor internalization and prolong signaling [3, 5]. Rescue experiments using wild-type versus mutant constructs help confirm specificity.
Imaging and proteomics
Live-cell imaging with fluorescently labeled receptors measures internalization rates and trafficking [2, 6]. Proteomics can identify interaction partners and post-translational modifications that regulate receptor fate [6, 8].
How CRISPR Can Be Used to Study GO:0002091 negative regulation of receptor internalization
Knockout
CRISPR knockout of candidate genes such as CNR2, IL1R2, or CXCR4 can reveal their role in negative regulation of receptor internalization [1, 2, 3]. By comparing surface receptor levels and signaling outputs in knockout versus wild-type cells, researchers can determine whether a gene inhibits internalization.
Point Mutation
Point mutations can be introduced into receptor intracellular domains to disrupt phosphorylation or ubiquitination sites, testing their role in internalization [2, 6]. This approach provides fine-grained mechanistic insight into GO:0002091.
Knock-in
Knock-in of tagged receptors or regulatory proteins allows tracking of internalization dynamics in live cells [4, 6]. Tagged knock-in models are valuable for studying real-time trafficking and post-translational modifications.
Overexpression
Overexpression of negative regulators such as IL-1R2 or CYSLTR1 can suppress receptor internalization and prolong signaling [3, 5]. This approach is useful for validating gain-of-function effects and for drug target screening.
How EDITGENE Supports negative regulation of receptor internalization Research
Researchers studying negative regulation of receptor internalization-related genes often need to determine whether a candidate gene is causally involved in receptor trafficking, signaling duration, or disease phenotypes. EDITGENE provides CRISPR-based cell model services to enable these functional studies with high specificity and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of receptor internalization research.
Frequently Asked Questions About negative regulation of receptor internalization
What is GO:0002091?
GO:0002091 is the Gene Ontology term for negative regulation of receptor internalization, defined as any process that stops, prevents, or reduces the frequency, rate or extent of receptor internalization [1, 4].
What genes are involved in negative regulation of receptor internalization?
Genes such as CNR2, CXCR4, IL1R2, TLR4, CYSLTR1, FCGR, and LPAR1 have been implicated in receptor internalization and its regulation [1, 2, 3, 4, 5, 6, 8].
How does negative regulation of receptor internalization work?
It works through mechanisms including receptor phosphorylation, ubiquitination, arrestin recruitment, and feedback loops that stabilize surface receptors [5, 6, 7].
Why is negative regulation of receptor internalization important in disease?
It can sustain pro-inflammatory or pro-survival signaling, contributing to diabetic heart injury, autoimmune diseases, and cancer [1, 2, 3].
What diseases are linked to defective receptor internalization?
Diabetic heart injury, autoimmune diseases, triple-negative breast cancer, and allergic inflammation have been linked to altered receptor internalization [1, 2, 3, 5].
How can CRISPR be used to study negative regulation of receptor internalization?
CRISPR knockout, point mutation, knock-in, and overexpression can test the causal role of specific genes in receptor trafficking [1, 2, 4, 6].
What methods measure receptor internalization?
Live-cell imaging, flow cytometry, proteomics, and RNA-seq are commonly used to measure internalization and downstream signaling [2, 6, 8].
What is the role of ubiquitination in receptor internalization?
Ubiquitination tags receptors for endocytic trafficking, and its reversal or inhibition can negatively regulate internalization.
Which receptors are controlled by GO:0002091?
GPCRs such as cannabinoid receptor 2 and CXCR4, cytokine receptors like IL-1R2, and Toll-like receptors are among those regulated [1, 2, 3, 4].
How does EDITGENE support research on receptor internalization?
EDITGENE provides CRISPR cell model services including knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics [1, 2, 8].
Conclusion
Negative regulation of receptor internalization (GO:0002091) is a fundamental biological process that controls the duration and intensity of cell surface receptor signaling. Through mechanisms such as phosphorylation, ubiquitination, and feedback loops, cells can keep receptors at the surface to sustain or modulate responses [1, 4, 6, 7]. Dysregulation of this process is linked to diabetic heart injury, autoimmune diseases, cancer, and inflammatory disorders [1, 2, 3, 5]. Researchers can leverage CRISPR-based models to dissect the genes and pathways involved in GO:0002091, enabling target discovery and therapeutic development. EDITGENE offers comprehensive services to support these efforts, from knockout and point mutation to library screening and bioinformatics [1, 2, 8].
References
- 1. Gao P et al.. 2023. Cannabinoid Receptor 2-Centric Molecular Feedback Loop Drives Necroptosis in Diabetic Heart Injuries.. Circulation 147(2):158-174 PMID: 36448459
- 2. Ho KKY et al.. 2025. Substrate stiffness regulates triple-negative breast cancer signaling through CXCR4 receptor dynamics.. Sci Rep 15(1):29621 PMID: 40796929
- 3. Zhang Y et al.. 2024. Negative regulator IL-1 receptor 2 (IL-1R2) and its roles in immune regulation of autoimmune diseases.. Int Immunopharmacol 136:112400 PMID: 38850793
- 4. Leifer CA et al.. 2016. Molecular mechanisms of regulation of Toll-like receptor signaling.. J Leukoc Biol 100(5):927-941 PMID: 27343013
- 5. Naik S et al.. 2005. Regulation of cysteinyl leukotriene type 1 receptor internalization and signaling.. J Biol Chem 280(10):8722-32 PMID: 15590629
- 6. Molfetta R et al.. 2014. Regulation of fc receptor endocytic trafficking by ubiquitination.. Front Immunol 5:449 PMID: 25278942
- 7. Sibley DR et al.. 1987. Regulation of transmembrane signaling by receptor phosphorylation.. Cell 48(6):913-22 PMID: 3030559
- 8. Zhao J et al.. 2021. Molecular Regulation of Lysophosphatidic Acid Receptor 1 Maturation and Desensitization.. Cell Biochem Biophys 79(3):477-483 PMID: 34032994
